MEI Pharma Reports Third Quarter Fiscal Year 2024 Results and Operational Highlights [Yahoo! Finance]
MEI Pharma Reports Third Quarter Fiscal Year 2024 Results and Operational Highlights
MEI Pharma, Inc. (NASDAQ: MEIP) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.
MEI Pharma, Inc. (NASDAQ: MEIP) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.
MEI Pharma, Inc. (NASDAQ: MEIP) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.